EE700 The Budget Impact of Venetoclax Plus Obinutuzumab for First-Line Chronic Lymphocytic Leukemia in Saudi Arabia
Abstract
Authors
A M. Alrajhi H. Al-Abdulkarim M Khan N Alkhudair H Alshehri A Fasseeh A Abd-El Aziz B Elezbawy S Abaza Y Ahmed A N. Sheriba A Semida F AlNajjar